New perspectives on retinoblastoma family functions in differentiation

Pediatric Pathology and Molecular Medicine

Volumn 18, Issue 3, 1998, Pages 275-302

  Yee, Amy S ^a   Shih, Heather H ^a   Tevosian, Sergei G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; E2F; HBP1; p107; p130; Retinoblastoma

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032322816     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15513819809168792     Document Type: Review

References (100)

1. Yan Z, DeGregori J, Shobet R, Leone G, Stillman B, Nevins JR, Williams RS. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 1998;95:3603-3608.
2. Krek W, Xu G, Livingston DM. Cyclin A-kinase regulation of E2F-1 binding function underlies suppression of an S-phase checkpoint. Cell 1995;83:1149-1158.
3. Dynlacht B, Flores O, Lees JA, Harlow E. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes and Dev 1994;8:1772-1786.
4. Xu M, Sheppard KA, Peng CY, Yee AS, Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 1994;14:8420-8431.
5. Farnham PJ. Transcriptional Control of Cell Growth: the E2F Family, vol. 208. New York: Springer Verlag, 1996.
6. Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 1997;173:233-236.
7. Mayol X, Grana X. The p130 pocket protein: keeping order at cell cycle exit/ re-entrance transitions. Front Biosci 1998;3:d11-24. http://www.bioscience.org/ 1998\v3\d\mayol\list.htm
8. Johnson DG, Schneider-Broussard R. The role of E2F in the cell cycle and cancer. Front Biosci 1998;3:d447-448. http://www.bioScience.org/ 1998\v3\d\johnsonl\list.htm
9. Campanero M, Flemington EK. Regulation of E2F through ubiquitin-proteosome dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci USA. 1997;94:2221-2226.
10. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes and Dev 1996;10:2960-2970.
11. Hoffmann F, Martelli F, Livingston DM, Wang Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes and Dev 1996;10:2949-2959.
12. Helin K, Holm K, Niebuhr A, Eiberg H, Tommerup N, Hougaard S, Poulsen HS, Spang-Thomsen M, Norgaard P. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci USA 1997;94:6933-6938.
13. Shan B, Durfee T, Lee WH. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl Acad Sci USA 1996;93:679-684.
14. Wang JYJ, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor gene. Adv in Cancer Res 1994;64:25-85.
15. Woo MS, Sanchez I, Dynlacht BD. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol 1997;17:3566-3579.
16. Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WGJ. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol 1996;16:6623-6633.
17. Paggi MG, Baldi A, Bonetto F, Giordano A. Retinoblastoma protein family in cell cycle and cancer: a review. Cell Biochem 1996;62:418-430.
18. Lin SC, Skapek SX, Lee EY. Genes in the RB pathway and their knockout in mice. Seminars Cancer Biol. 1996;7:279-289.
19. Jacks T, Fazeli EM, Schmitt E, Bronson RT, Goodell MA and Weinberg RA. Effects of an Rb mutation in mice. Nature (London) 1992;359:295-300.
20. Lee EY-HP, Hu N, Yuan S-SF, Cox L, Bradley A, Lee W-H, Herrup K. Dual roles of the retinoblastoma proteins in cell cycle regulation and neuron differentiation. Genes and Dev 1994;8:2008-2021.
21. Lee EHYP, Chang CY, Hu N, Wang YCJ, Lai CC, Herrup K, Lee W-H, Bradley A. Mice deficient for Rb are nonviable and show defects in neuogenesis and hematopoiesis. Nature (London) 1992;359:288-294.
22. Riley DJ, Lee EY-HP, Lee W-H. The retinoblastoma protein: more than a tumor suppressor. Ann Rev Cell Biol 1994;10:1-29.
23. Zackenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes and Dev 1996;10:3051-3064.
24. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. Shared role of the pRB-related p130 and p107 protein in limb development. Genes and Dev 1996;10:1633-1644.
25. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. Targeted disruption of p107: functional overlap between p107 and Rb. Genes and Dev 1996;10:1621-1632.
26. Hurford RK, Cobrinik D, Lee MH, Dyson N. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes and Dev 1997;11:1447-1463.
27. Mulligan GJ, Wong J, Jacks T. p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB. Mol Cell Biol 1998;18:206-220.
28. Tevosian SG, Shih H, Mendelson KG, Sheppard KA, Paulson KE, Yee AS. HBP-1: A new transcriptional repressor that is targeted of the retinoblastoma family. Genes and Dev 1997;11:383-396.
29. Maione R, Fimia G, Holman P, Schaffhausen B, Amati P. Retinoblastoma antioncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Diff 1994;5:231-237.
30. Corbeil H, Whyte P, Branton PE. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 1995;11:909-920.
31. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 1994;264:1467-1470.
32. Maione R, Amati P. Interdependence between muscle differentiation and cell cycle control. Biochim Biophys Acta 1997;1332:M19-M30.
33. Mayol X, Garriga J, Grana X. G1 cyclin/CDK independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with p130. Oncogene 1996;13:237-246.
34. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol 1996;16:6965-6976.
35. Shin E, Shin A, Paulding C, Schaffhausen B, Yee AS. Multiple changes in E2F transcription factor function occur upon muscle differentiation. Mol Cell Biol 1995;15:2252-2262.
36. Cobrinik D, Whyte P, Peeper D, Jacks T, Weinberg R. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes and Dev 1993;7:2392-2404.
37. Altiok S, Xu M, Spiegelman BM. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes and Dev 1997;11:1987-1998.
38. Sellers WR, Kaelin WGJ. RB [corrected] as a modulator of transcription. Biochim Biophys Acta 1288(1), M1-M5 (1996).
39. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchanbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992;70:351-364.
40. Sellers WR, Rodgers JW, Kaelin WGJ. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA. 1995;92:11544-11548.
41. Chow KN, Dean DC. Domains A and B in the RB pocket interact to form a transcriptional repressor motif. Mol Cell Biol 1996;16:4862-4868.
42. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (London) 1998;391:597-600.
43. Luo R, Postigio A, Dean DC. RB interacts with histone deacetylase to repress transcription. Cell 1998;92:642-473.
44. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Villain JP, Troalen F, Trouche D, Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature (London) 1998;391:601-604.
45. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes and Dev 1998;12:599-606.
46. Yee AS, Raychaudhuri P, Jakoi L, Nevins JR. The adenovirus-inducible factor E2F stimulates transcription following specific DNA binding. Mol Cell Biol 1989;9:578-585.
47. Singh P, Coe J, Hong W. A role for the retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature (London) 1995;374:562-565.
48. Defeo-Jones D, Huang P, Jones R, Haskell K, Vuocolo G, Hanobik M, Huber H, Oliff A. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (London) 1991;352:251-253.
49. Dowdy SF, Hinds PW, Louie P, Reed SI, Weinberg RA. Physical interaction of the retinoblastoma protein with D-type cyclins. Cell 1993;73:499-511.
50. Ewen M, Sluss HK, Sherr CJ, Matsuhime H, Kato J, Livingston DM. Functional interactions of retinoblastoma and D-type cyclins. Cell 1993;73:487-497.
51. Buyse I, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus EIA protein. Proc Natl Acad Sci USA 1995;92:4467-4471.
52. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree G, Goff S. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994;79:119-130.
53. Wang CY, Petryniak B, Thompson CB, Kaelin WG, Leiden JM. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 1993;1330-1335.
54. Lavender P, Vandel L, Bannister AJ, Kouzarides T. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 1997;14:2721-2728.
55. Lesage F, Hugnot JP, Amri EZ, Grimaldi P, Barhanin J, Lazdunski M. Expression cloning in the K + transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucl Acids Res 1994;22:3685-3688.
56. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE. Structural basis for DNA bending by the architectual transcription factor Lef-1. Nature (London) 1995;376:791-795.
57. Grosschedl R. Higher order nucleoprotein complexes in transcription: analogies with site-specific recombination. Current Opin Cell Biol 1995;7:362-370.
58. Hunter T. Oncoprotein Networks. Cell 1997;88:333-346.
59. Mudryj M, Hiebert S, Nevins JR. A role for the adenovirus-inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J 1990;9:2179-2184.
60. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
61. Novitch BG, Mulligan GJ, Jacks T, Lassar AB. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol 1996;135:441-156.
62. Wang JYJ. Retinoblastoma protein in growth suppression and death. Curr Opin Gen & Dev 1997;7:39-45.
63. Almasan A, Yin Y, Kelly RE, Lee EYHP, Bradley A, Li W, Bertino J, Wahl GM. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes and apoptosis. Proc Natl Acad Sci USA. 1995;92:5436-5440.
64. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung Y, Israel M. Inhibition of apoptosis by the retinoblastoma gene. EMBO J 1995;14:461-472.
65. Tan X, Martin SJ, Green DR, Wang JYJ. Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 1997;272:9613-9616.
66. Janicke RU, Walker PA, Lin XY, Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996;15:6969-6978.
67. Dou Q.-P, An B. RB and apoptotic cell death. Front/Biosci 1998;3:d419-430. http://www.bioscience.org/1998\v3\d\dou\list.htm
68. Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Gen & Dev 1997;7:597-602.
69. Morgenbesser SD, Williams BO, Jacks TL, Depinho RA. p53-dependendent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (London) 1996;371:72-74.
70. Macleod KF, Hu Y, Jacks T. Loss of RB activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996;15:6178-88.
71. Wang J, Walsh K. Resistance to apoptosis conferred by cdk inhibitors in myocyte differentiation. Science 1996;273:359-361.
72. Guo K, Wang J, Andres V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995;15:3823-3829.
73. Halavey O, Novitch B, Spacer DB, Skapek S, Rhee J, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995;267:1018-1021.
74. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ. p53-independent expression of p21 cip1 in muscle and other terminally differentiated cells. Science 1995;267:1024-1026.
75. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes and Dev 1995;9:935-944.
76. Wang J, Guo K, Wills KN, Walsh K. RB functions to inhibit apoptosi during myocyte differentiation. Cancer Res 1997;57:351-354.
77. Molkentin JD, Olson EN. Defining the regulatory networks for muscle development. Curr Opin Genetics Dev 1996;6:445-453.
78. Molkentinin J and Olson EN. Combinatorial control of muscle development by helix-loop-helix and MADS box transcription factors. Proc Natl Acad Sci USA 1996;93:9366-9373.
79. Condorelli G, Giordano A. Synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation. J Cell Biochem 1997;67:423-431.
80. Olson EN, Klein WH. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes and Dev 1994;8:1-8.
81. Brun RP, Kim JB, Hu E, Altiok S, Spiegelman BM. Adipocyte differentiation: a transcriptional regulatory cascade. Current Opin Cell Biol 1996;6:826.
82. Peterson C, Gordon H, Hall Z, Paterson B, Blau H. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 1990;62:493-502.
83. Puri PL, Balsano C, Burgio VL, Chirillo P, Natoli G, Ricci L, Mattei E, Graessmann A, Levrero M. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes. Oncogene 1997;14:1171-1184.
84. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadai-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993;72:309-324.
85. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes and Dev 1995;9:168-181.
86. Chen PL, Riley DJ, Chen Y, Lee WH. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes and Dev 1996;10:2794-2804.
87. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lasser AB, Kaelin WGJ. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation and suppress tumor cell growth. Genes and Dev 1998;12:95-106.
88. Riley DJ, Liu CY, Lee WH. Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression. Mol Cell Biol 1997;17:7342-7352.
89. Batchvarova N, Wang XZ, Ron D. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J 1995;14:4654-4661.
90. Shih H, Tevosian SG, Yee AS. Regulation of Differentiation by HBP1, a Target of the Retinoblastoma Protein. Mol Cell Biol 1998;18:4732-43.
91. Datta B, Min W, Burma S, Lengyel P. Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity of p202. Mol Cell Biol 1998;18:1074-1083.
92. Classon M, Gorka C, Kennedy BK, Dyson N, Harlow E. Opposing roles for pRB and p107/p130 in adipocyte differentiation, submitted.
93. Choubey D, Lengyel P. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J Biol Chem 1995;270:6134-6140.
94. Choubey D, Li S-J, Datta B, Gutterman JU, Lengyel P. Inhibition of E2F-mediated transcription by p202. EMBO J 1996;15:5668-5678.
95. Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes and Dev 1992;6:439-453.
96. Crozat A, Aman P, Mandahl N and Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (London) 1993;363:640-644.
97. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev 1994;8:453-464.
98. Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK, Dotto GP. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 1998;280:1069-1072.
99. Sugiyama A, Miyagi Y, Shirasawa Y, Kuchino T. Different usage of two polyadenylation signals in transcription of the N-Myc gene in rat tumor cells. Oncogene 1991;11:2027-2032.
100. Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci USA 1995;23:12861.